Recent Advances in Intranasal Administration for Brain-Targeting Delivery: A Comprehensive Review of Lipid-Based Nanoparticles and Stimuli-Responsive Gel Formulations
International Journal of Nanomedicine · 2024-02 · Volume 19 · 1767-1807
DOI: 10.2147/ijn.s439181 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Nanomedicine, 2024-02. Verfasst von Jain Koo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Global Innovative Drugs, The Graduate School of Chung-Ang University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Liposomes, Nanoparticles. Die Arbeit wurde bisher 176-mal zitiert (Crossref) und nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Addressing disorders related to the central nervous system (CNS) remains a complex challenge because of the presence of the blood-brain barrier (BBB), which restricts the entry of external substances into the brain tissue. Consequently, finding ways to overcome the limited therapeutic effect imposed by the BBB has become a central goal in advancing delivery systems targeted to the brain. In this context, the intranasal route has emerged as a promising solution for delivering treatments directly from the nose to the brain through the olfactory and trigeminal nerve pathways and thus, bypassing the BBB. The use of lipid-based nanoparticles, including nano/microemulsions, liposomes, solid lipid nanoparticles, and nanostructured lipid carriers, has shown promise in enhancing the efficiency of nose-to-brain delivery. These nanoparticles facilitate drug absorption from the nasal membrane. Additionally, the in situ gel (ISG) system has gained attention owing to its ability to extend the retention time of administered formulations within the nasal cavity. When combined with lipid-based nanoparticles, the ISG system creates a synergistic effect, further enhancing the overall effectiveness of brain-targeted delivery strategies. This comprehensive review provides a thorough investigation of intranasal administration. It delves into the strengths and limitations of this specific delivery route by considering the anatomical complexities and influential factors that play a role during dosing. Furthermore, this study introduces strategic approaches for incorporating nanoparticles and ISG delivery within the framework of intranasal applications. Finally, the review provides recent information on approved products and the clinical trial status of products related to intranasal administration, along with the inclusion of quality-by-design-related insights.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Global Innovative Drugs, The Graduate School of Chung-Ang University, Seoul, Republic of Korea.
- College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea.
- College of Pharmacy, CHA University, Seongnam-si, Gyeonggi-do, Republic of Korea.
ORCID-Profile: Kyung Taek Oh
Zitieren
APA
Koo, J., Lim, C., & Oh, K. T. (2024). Recent Advances in Intranasal Administration for Brain-Targeting Delivery: A Comprehensive Review of Lipid-Based Nanoparticles and Stimuli-Responsive Gel Formulations. International Journal of Nanomedicine, Volume 19, 1767-1807. https://doi.org/10.2147/ijn.s439181
Vancouver
Koo J, Lim C, Oh KT. Recent Advances in Intranasal Administration for Brain-Targeting Delivery: A Comprehensive Review of Lipid-Based Nanoparticles and Stimuli-Responsive Gel Formulations. International Journal of Nanomedicine. 2024;Volume 19:1767-1807. doi:10.2147/ijn.s439181
BibTeX
@article{Koo2024,
author = {Koo, Jain and Lim, Chaemin and Oh, Kyung Taek},
title = {Recent Advances in Intranasal Administration for Brain-Targeting Delivery: A Comprehensive Review of Lipid-Based Nanoparticles and Stimuli-Responsive Gel Formulations},
journal = {International Journal of Nanomedicine},
year = {2024},
volume = {Volume 19},
pages = {1767--1807},
doi = {10.2147/ijn.s439181}
}
EUVIMED